24 results on '"Ching-Wei D Tzeng"'
Search Results
2. 1029: SAFETY AND OUTCOMES OF REPEATED LIVER RESECTION FOR COLORECTAL LIVER METASTASES: A REVIEW OF 23 YEARS OF HEPATECTOMY DATA
3. 759: OPIOID REDUCTION FOLLOWING MINIMALLY INVASIVE LIVER SURGERY: AIMING BEYOND INCISION SIZE
4. 917: BENCHMARK ANALYSIS: MULTI-INSTITUTIONAL COOPERATIVE COHORT FOR GALLBLADDER CANCER SURGERY
5. 1027: SURVIVAL OUTCOME OF TWO OR MORE RESECTIONS OF RECURRENCE WITH OR WITHOUT EXTRAHEPATIC DISEASE AFTER FIRST CURATIVE RESECTION FOR COLORECTAL LIVER METASTASES
6. 131: MITIGATING MORBIDITY IN OLDER PATIENTS UNDERGOING MAJOR PANCREATIC AND HEPATOBILIARY SURGERY
7. 918: REAL WORLD DATA SUPPORTS POST-PANDEMIC CONTINUATION OF TELEMEDICINE SURVEILLANCE VISITS FOLLOWING RESECTION OF COLORECTAL LIVER METASTASES
8. 1037: INCIDENCE OF AND RISK FACTORS FOR INCISIONAL HERNIA AFTER OPEN HEPATECTOMY FOR COLORECTAL LIVER METASTASES
9. 44: DEVELOPMENT OF AN ACCUMULATION INDEX TO IDENTIFY PANCREATIC SIDE BRANCH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS WITH UNDERLYING MALIGNANCY
10. 316: PROSPECTIVE STUDY OF PERIOPERATIVE CIRCULATING TUMOR DNA DYNAMICS IN PATIENTS UNDERGOING HEPATECTOMY FOR COLORECTAL LIVER METASTASES
11. 1031: DEFINING THE ROLE OF ADJUVANT RADIOTHERAPY FOR BILE DUCT CANCERS: A SITE-SPECIFIC PROPENSITY-MATCHED ANALYSIS
12. Fr644 POST-HEPATECTOMY PATHWAYS: USING INPATIENT RISK-STRATIFICATION TO INFORM OUTPATIENT FOLLOW-UP
13. 767 OUTCOMES OF MIXED PATHOLOGIC RESPONSE IN PATIENTS WITH MULTIPLE COLORECTAL LIVER METASTASES TREATED WITH NEOADJUVANT CHEMOTHERAPY AND LIVER RESECTION
14. 1 NEITHER SURGICAL MARGIN STATUS NOR SOMATIC MUTATION PREDICTS LOCAL RECURRENCE AFTER R0-INTENT RESECTION FOR COLORECTAL LIVER METASTASES
15. 309 IMPLEMENTATION OF AN AUTOMATED DATA ABSTRACTION WORKFLOW TO FACILITATE QUALITY IMPROVEMENT AND RESEARCH
16. 327 DISPARITIES IN USE OF SURGICAL TREATMENTS MEDIATE HALF OF SOCIOECONOMIC SURVIVAL DISPARITIES IN STAGE I-II HEPATOCELLULAR CARCINOMA
17. 900 UTILIZATION OF THE KAWAGUCHI-GAYET COMPLEXITY CLASSIFICATION TO CREATE, IMPLEMENT, AND VALIDATE RISK-STRATIFIED POST-HEPATECTOMY PATHWAYS BASED ON ANTICIPATED LENGTH OF STAY
18. 639 ITERATIVE CHANGES IN RISK-STRATIFIED PANCREATECTOMY CLINICAL PATHWAYS AND FACTORS ASSOCIATED WITH ACCELERATED DISCHARGE AFTER PANCREATICODUODENECTOMY
19. Sa670 INCIDENCE OF POSTOPERATIVE COMPLICATIONS FOLLOWING RESECTION FOR MUCINOUS CYSTIC LESIONS VERSUS PANCREATIC DUCTAL ADENOCARCINOMA
20. 633 SURVIVAL IN PATIENTS WITH COLORECTAL LIVER METASTASES IS ASSOCIATED WITH MULTIMODALITY CAPACITY OF THE TREATING FACILITY
21. 634 EVERY DROP MATTERS: INTRAOPERATIVE FLUIDS DURING HEPATECTOMY AND POSTOPERATIVE ILEUS
22. 363 Safety and Efficacy of Portal Vein Embolization Before Planned Major Hepatectomy: An Institutional Experience of 358 Patients
23. 200 Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion Rates and Survival
24. 778 Morbidity and Mortality After Pancreaticoduodenectomy in Patients With Borderline Resectable Type C Clinical Classification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.